AI-generated summary
This review discusses melasma and postinflammatory hyperpigmentation, two common forms of skin darkening in patients with skin of color, and their diagnosis and treatment. The authors describe multimodal approaches including sun protection, topical and systemic medications, and procedures, and note that topical hydroquinone remains a mainstay with alternatives showing varying promise. The abstract does not report any new patient data.
- Who or what was studied
- Patients with skin of color affected by melasma or postinflammatory hyperpigmentation
- Limits stated in the abstract
- The abstract describes a narrative review and reports no quantitative findings on treatment efficacy or safety.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.